Study demonstrates capability of generative reinforcement learning in drug discovery
Small molecules developed using generative reinforcement learning have been validated in in vitro and in vivo studies for the first time. Could this machine-learning approach revolutionize drug discovery?
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>